Listar por tema "high flow nasal cannula therapy"

Mostrando ítems 1-1 de 1

Tocilizumab in COVID-19: Enthusiasm vs. evidence

Zena-Huancas, P.; Leon-Jimenez, F.; Bryce-Alberti, M.; Portmann Baracco, Arianna Sibila (Wolters Kluwer Health, 2021)

Based on the pathophysiological characterization of COVID-19, initial studies suggested the use of tocilizumab (TCZ), a recombinant humanized monoclonal antibody of the immunoglobulin G1 class, for management of the cytokine ...